The data shows that the drugs triggered activity in the central amygdala that reduced dopamine release into the brain's reward circuitry.

A study has found that an emerging class of GLP-1 weight-loss drugs suppresses eating for pleasure, or hedonic feeding, in ...

A UCLA-led international research collaboration has unveiled a new technology that may help scientists better understand how ...

Key opportunities in the small molecule innovator CDMO market include rising outsourcing by biotech firms, demand for rapid ...

A molecule so small it could fit on a Post-it note of genetic code has just pulled off something scientists have chased for ...

Small molecule drugs dominate new drug approvals and are crucial for treating diverse diseases. They are typically low-weight, providing easy absorption and versatile delivery methods. Their simpler ...

Telomeres, posted at the edges of chromosomes, protect DNA from damage. The telomerase enzyme helps maintain the length and integrity of telomeres and acts as an aging regulator. Researchers have now ...

Recent research highlights an approach in cancer therapy with small molecule drugs targeting immune checkpoints. These innovative drugs overcome the limitations of antibody-based inhibitors, such as ...

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical-stage biotechnology company advancing precision oncology through its ...